login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Novel Prostate Cancer Drug Target Identified
Dr. Liu and his team discovered a protein called ARD1 which is involved with the male hormone, androgen, and its receptor. Prostate cancer is a hormone-regulated disease and the main hormone is androgen. Androgen activates its receptor - androgen receptor (AR) to play a critical role in the development and progression of prostate cancer. Therefore, androgen deprivation therapy has been a standard treatment for advanced prostate cancer.
"However, a majority of tumors invariably relapse and become an androgen-independent prostate cancer from which most patients eventually die," notes Dr. Liu, who is also a member of the LSUHSC Stanley S. Scott Cancer Center.
To find an alternative strategy to treat prostate cancer, Dr. Liu's group is studying androgen receptor activators and increasing levels of these activators leading to prostate cancer. Following the discovery of this new protein, they determined that ARD1 is overproduced in the majority of prostate cancer samples, that it activates the androgen receptor, and that it is an essential component of prostate cancer cell growth.
"In addition, we demonstrated that inactivation of ARD1 inhibits the function of androgen receptors resulting in complete suppression of prostate cancer cell growth in tissue culture and prostate tumor growth in mice," reports Dr. Liu. "Furthermore, we revealed that the role of ARD1 in the development of prostate cancer is to modify the androgen receptor to enhance its activity."
According to the National Cancer Institute, about 242,000 American men will be diagnosed with prostate cancer this year. It is the second most diagnosed cancer among men, only behind skin cancer. An estimated 28,170 men will die from prostate cancer in 2012.
"Our study provides a novel avenue for controlling AR-mediated prostate tumor development by directly inhibiting the function of ARD1 or AR-ARD1 interaction," says Dr. Liu. "Developing an ARD1-specific inhibitor or an AR-ARD1 interaction-disrupting compound may be of therapeutic benefit in the treatment of prostate cancer."
Source-Eurekalert
|
|
More News on: Drug Toxicity, Prostate Cancer, Cancer and Homeopathy, Check your prostate gland, Prostatitis Symptom Score Calculator, Trans-Urethral Resection of the Prostate, Signature Drug Toxicity, Prostate Cancer Facts, Cancer Facts, Cancer
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
 | Quiz on Cancer Looking for information on cancer? Go through medindia's Cancer quiz. 
|
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Cancer
Complete Medindia Resources
|
| News Categories: |
| » | San Francisco to Celebrate Golden Gate Bridge’s 75th Anniversary |
| » | Shoppers to Generate Electricity by Walking Over Special Tiles in London Shopping Mall |
| » | Aussies Prefer Freelance or Part Time Work to Traditional 9-5 Job |
| » | Many Brits Opt for Indian Surrogate Mothers |
| » | 'Ketchup Problem' Finally Solved: Researchers |
| More Life Style News | |
|
Drug Related News |
||||||||
| » | New Quality Standards in Medicines | » | Drug for Irregular Heartbeat Gets Green Signal | |||||
| » | Schizophrenia Drug Differentiates Cancer Stem Cells into Less Threatening Cells | » | Docs Who Seldom Meet Drug Reps Continue to Prescribe Drugs With FDA “Black Box” Warnings | |||||
| » | Revision in Quality Standards for Heparin | » | Acne Drug Users At High Risk of Developing Eye Infections | |||||
| » | Patients Who Take Antidepressants When in ICU More Likely to Die | » | New Tablet Coating Product by Ideal Cures, In Geneva | |||||
| Read More >> | ||||||||
